OHSU Study Uncovers Mechanisms Behind Pancreatic Cancer’s Resistance to Immunotherapy
In a groundbreaking study published in the prestigious journal Immunity, researchers from Oregon Health & Science University (OHSU) have shed ...
Tag: Immune checkpoint inhibitors limitations
mRNA-Encoded Nanobodies Emerge as Promising Therapeutics for Colorectal Cancer
A pioneering leap in cancer immunotherapy has emerged from recent research, unveiling a novel intervention against colorectal cancer through mRNA-encoded ...
SLAMF6: Drug Target to Boost T Cell Immunity
In a groundbreaking study that promises to reshape the landscape of cancer immunotherapy, researchers have unveiled the pivotal role of ...
Trispecific Engager Surmounts Tumor Immunosuppression Challenges
In a groundbreaking study set to redefine the landscape of cancer immunotherapy, researchers have unveiled a novel trispecific engager designed ...
Antibody-Drug Conjugates Enhance Outcomes in Advanced Triple-Negative Breast Cancer Patients Unsuitable for Immune Checkpoint Inhibitors
In a groundbreaking advancement in the treatment of aggressive breast cancers, researchers have unveiled promising results from the ASCENT-03 trial, ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!